Literature DB >> 7387142

Absorption and disposition kinetics of amoxicillin in normal human subjects.

A Arancibia, J Guttmann, G González, C González.   

Abstract

Pharmacokinetic parameters of amoxicillin were studied in healthy fasted subjects afqer both oral and intravenous administration of a single 500-mg dose. Serum levels and urinary excretion rates were determined at various time intervals by a microbiological method. The conventional two-compartment model with elimination occurring from the central compartment was used to analyze the data. Mean values were 3.40 h-1 for alpha and 0.68 h-1 for beta. Distribution constants kappa 12 and kappa 21 were 0.92 h-1 and 1.99 h-1, respectively. The rate constant for elimination from the central compartment, kappa 10, was 1.16 h-1. The volume of distribution was 20.2 liters (0.30 liter/kg), and the serum clearance was 13.3 liters/h. The absorption rate constant, kappa a, in the oral study, calculated by the Loo-Riegelman method, was 1.02 h-1, and the absorption half-life was 0.72 h. Absolute bioavailability after the oral dose was determined by comparing both the areas under the curve (AUC) and fractions of the antibiotic excreted unchanged in the urine. The AUC after oral administration was 77.4% of the intravenous AUC. On the other hand, recovery from the urine was 43.4% after the oral dose and 57.4% after the intravenous dose, indicating 76.5% bioavailability.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387142      PMCID: PMC283758          DOI: 10.1128/AAC.17.2.199

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Trial of a new broad-spectrum penicillin (amoxycillin) in general practice.

Authors:  J W Harding; L J Lees
Journal:  Practitioner       Date:  1972-09

2.  Preliminary clinical study with amoxycillin (BRL 2333) in complicated lower respiratory tract infections.

Authors:  J Stam
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

3.  Amoxicillin therapy of infections.

Authors:  C Vallejos; V Rodriguez; J A Gottlieb; G P Bodey
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

4.  Amoxycillin (BRL 2333) in children. Serum concentrations and clinical report.

Authors:  K F Kerrebijn; M F Michel
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

5.  [Ten cases of urinary infections treated with alpha-aminohydroxybenzylpenicillin].

Authors:  R Gómez-Lus; M C Rubio Calvo; L Gómez López; M P Millán
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

6.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

7.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

8.  An in vitro and pharmacological comparison of amoxicillin and ampicillin.

Authors:  J L Brusch; M G Bergeron; M Barza; L Weinstein
Journal:  Am J Med Sci       Date:  1974-01       Impact factor: 2.378

9.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.

Authors:  E A Croydon; R Sutherland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

10.  Amoxicillin: in vitro and pharmacological studies.

Authors:  G P Bodey; J Nance
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  23 in total

Review 1.  New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.

Authors:  Amparo Sánchez Navarro
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

3.  Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.

Authors:  Marina Becker Sales Rocha; Gilberto De Nucci; Francisco Ney Lemos; Rodrigo Feitosa de Albuquerque Lima Babadopulos; Andrea Vieira Pontes Rohleder; Francisco Vagnaldo Fechine; Natalícia J Antunes; Gustavo D Mendes; Demetrius Fernandes do Nascimento; Manoel Odorico de Moraes; Maria Elisabete Amaral de Moraes
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

4.  Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.

Authors:  G Witkowski; H Lode; G Höffken; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

5.  Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center.

Authors:  Anne Fournier; Sylvain Goutelle; Yok-Ai Que; Philippe Eggimann; Olivier Pantet; Farshid Sadeghipour; Pierre Voirol; Chantal Csajka
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

6.  Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Authors:  Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

7.  Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

8.  An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion.

Authors:  K Vance-Bryan; T A Larson; M W Garrison; J P Toscano; D M Canafax; J C Rotschafer
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

9.  Determination of dose-dependent absorption of amoxycillin from urinary excretion data in healthy subjects.

Authors:  S Chulavatnatol; B G Charles
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

10.  Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome.

Authors:  Damien J Cabral; Swathi Penumutchu; Elizabeth M Reinhart; Cheng Zhang; Benjamin J Korry; Jenna I Wurster; Rachael Nilson; August Guang; William H Sano; Aislinn D Rowan-Nash; Hu Li; Peter Belenky
Journal:  Cell Metab       Date:  2019-09-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.